| Literature DB >> 30203366 |
Chang Soo Ryu1, Jung Hyun Sakong1, Eun Hee Ahn2, Jung Oh Kim1, Daeun Ko3, Ji Hyang Kim2, Woo Sik Lee4, Nam Keun Kim5.
Abstract
This study was purposed to investigate whether genetic polymorphisms in the function of stop-gain are associated with a fetal or placental development play roles and a development of idiopathic recurrent pregnancy loss (RPL) in Korean females. Three stop-gain polymorphisms were selected using next-generation sequencing screening, which allows for the rigorous examination and discovery of previously uncharacterized stop-gain genes and stop-gain expression profiles. Accordingly, we investigated the association of stop-gain polymorphisms in Korean women with RPL. Three functional polymorphisms in the TAS2R46G>A (rs2708381), OR4C16G>A (rs1459101), and OR4X1A>T (rs10838851) genes were genotyped using polymerase chain reaction (PCR)-restriction fragment length polymorphism assays and real-time PCR analysis. We determined that the OR4C16G>A polymorphism was associated with idiopathic RPL in Korean women (Adjusted odds ratio [AOR] 1.782; 95% confidence interval [CI] 1.004-3.163; P = 0.048, and AOR 1.766; 95% CI 1.020-3.059; P = 0.042). In addition, the prevalence of RPL was increased in women with the OR4C16GA + AA genotype and blood coagulation measures of prothrombin time (PT) > 10.4 s (AOR 8.292; 95% CI 2.744-25.054). We suggest that the OR4C16G>A polymorphism might serve as a clinically useful biomarker for the development, prevention, and prognosis of RPL.Entities:
Keywords: Next-generation sequencing (NGS); Nonsense mutation; Polymorphism; Recurrent pregnancy loss (RPL); Stop gain mutation
Mesh:
Substances:
Year: 2018 PMID: 30203366 DOI: 10.1007/s13258-018-0738-5
Source DB: PubMed Journal: Genes Genomics ISSN: 1976-9571 Impact factor: 1.839